NON-SURGICAL DOUBLE CHIN TREATMENT (BELKYRA®)
Putting Patients First
Carefiniti Health is pleased to offer Belkyra treatments to our patients. This is a revolutionary, FDA-approved double chin treatment, which requires absolutely no surgery. Through a series of targeted injections, the fat in the double chin is gradually destroyed, creating a tighter appearance in the neck, and achieving a more aesthetically-pleasing transition between the jaw and the neck.
In many ways, using Belkyra is like sculpting a marble statue; great care must be taken to remove the right amount of fat under the chin to create an appearance that looks natural and provides the right contours.
If you have any questions about Kybella treatments or would like to schedule a consultation, please give us a call.
WHAT YOU NEED TO KNOW ABOUT BELKYRA®
What is Belkyra®?
Belkyra® is an injectable treatment that permanently dissolves fat. It is a synthetic form of a natural bile acid called deoxycholic acid, usually released by our liver to digest a fatty meal.
What does Belkyra do, and who is suitable for treatment?
Belkyra® is injected into the fat under your chin to contour your jawline and reduce your double chin. It’s suitable for moderate to severe double chins caused by fat accumulation from genes, ageing or weight gain. Other causes of a double chin, such as loss of skin elasticity or muscle excess, will not respond to treatment. We’ll assess your neck area to see if your chin is suitable. You will need at least two treatments spaced eight weeks apart. Most people need three to four treatments. You may require up to six treatments. Although the reduction in fat cells is irreversible, the appearance of your double chin area may be affected over time by skin ageing, weight changes and sun exposure.
​
Who should not have treatment with Belkyra?
You should not have treatment if you are pregnant or breast-feeding, have active skin disorders in the area, have hepatitis, chronic liver disease, HIV or known hypersensitivity to deoxycholic acid or local anaesthetic. Caution is required in patients with a history of autoimmune disease or disease affecting the immune system.
​
Possible adverse effects?
Belkyra® is approved only for use in the submental area. Common side effects like swelling or bruising should resolve within a few days. There is a risk of serious side effects that include nerve injury in the jaw. This can result in facial weakness or asymmetry, difficulty with swallowing or destroying the skin cells if injected in a wrong depth. For this reason, it’s essential to choose a qualified cosmetic physician to perform the procedure. Other healthcare professionals may not have adequate familiarity with variations in anatomy in the area of the chin and jaw. Patients with severe double chin may develop excessive loose skin after treatment of the submental fat. This can be improved with surgical tightening procedures or by use of non-invasive treatments.